Pay in 4 interest-free payments of $5.16 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
In Silico Pharmacogenomic Assessment of Glucagon-like Peptide-1 (GLP1) Agonists and the Genetic Addiction Risk Score (GARS) Related Pathways: Implications for Suicide Ideation and Substance Use Disorder
D.EstallJ
In addition, studies of bariatric surgery in overweight or obese individuals versus matched controls also showed decreased incidence of obesity-related cancers and decreased cancer-related mortality
Patients with obesity are more likely to discontinue GLP-1 therapy than those with diabetes, citing lower perceived necessity, stigma, and limited coverage as key drivers 7
US$ 26.80
US$ 24.04
US$ 27.18
US$ 29.77
US$ 24.95
US$ 20.03
